Cohorts | ADNI-1 | ADNI-GO | ADNI-2 |
---|---|---|---|
Total, No. | 585 | 109 | 661 |
Age, mean (SD), y | 74.8 (6.8) | 71.5 (7.6) | 72.4 (7.1) |
Female, No. (%) | 233 (39.8%) | 47 (43.1%) | 307 (46.4%) |
Baseline Diagnosis, No. (%) | Â | Â | Â |
 CN | 161 (27.5%) | - | 238 (36.0%) |
 MCI | 301 (51.5%) | 109 (100%) | 300 (45.4%) |
 AD | 123 (21.0%) | - | 123 (18.6%) |
Progression from CN to MCI, No. (%) | Â | Â | Â |
 Yes | 38 (26.2%) | - | 25 (11.7%) |
 No | 107 (73.8%) | - | 189 (88.3%) |
Progression from MCI to AD, No. (%) | Â | Â | Â |
 Yes | 155 (57.2%) | 12 (14.6%) | 77 (30.8%) |
 No | 116 (42.8%) | 70 (85.4%) | 173 (69.2%) |